Clinical Trial Update: Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries [Phase 3]

View source ↗

Summary

Phase 3 crossover trial comparing two gadolinium-based contrast agents for MR angiography of carotid, renal, and peripheral arteries; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Disease
• Carotid Artery Disease
• Peripheral Artery Disease
• Renal Artery Disease

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Carotid, Aortic, Renal or Peripheral Artery Disease | Phase 3 | Status: COMPLETED